BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen Y, Xie J, Wu W, Li S, Hu Y, Hu M, Li J, Yang Y, Huang T, Zheng K, Wang Y, Kang H, Huang Y, Jiang L, Zhang W, Zhong M, Sang L, Zheng X, Pan C, Zheng R, Li X, Tong Z, Qiu H, Weng L, Du B. Intravenous Immunoglobulin Therapy for Critically Ill COVID-19 Patients With Different Inflammatory Phenotypes: A Multicenter, Retrospective Study. Front Immunol 2021;12:738532. [PMID: 35154067 DOI: 10.3389/fimmu.2021.738532] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Liu X, Zhang Y, Lu L, Li X, Wu Y, Yang Y, Li T, Cao W. Benefits of high-dose intravenous immunoglobulin on mortality in patients with severe COVID-19: An updated systematic review and meta-analysis. Front Immunol 2023;14:1116738. [PMID: 36756131 DOI: 10.3389/fimmu.2023.1116738] [Reference Citation Analysis]
2 Wang G, He Z, Wu F, Ge Z, Zhu J, Chen Z. IgG response to spike protein of SARS-CoV-2 in healthy individuals and potential of intravenous IgG as treatment for COVID-19. Virol J 2022;19:186. [DOI: 10.1186/s12985-022-01921-z] [Reference Citation Analysis]
3 Liu S, Huang Z, Fan R, Jia J, Deng X, Zou X, Li H, Cao B. Cycling and activated CD8+ T lymphocytes and their association with disease severity in influenza patients. BMC Immunol 2022;23:40. [PMID: 36064355 DOI: 10.1186/s12865-022-00516-1] [Reference Citation Analysis]